Advertisement

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Abbott Laboratories: “Talatrol Abbott” Abbott Laboratories, North Chicago, Illinois mimeo 1962.Google Scholar
  2. Aber, G. M., Bayley, T. J., Bishop, J. M.: The effect of THAM infusion on simultaneously studied cardiac, respiratory and renal function in patients with obstructive airway disease. Clin. Sci. 25, 171–180 (1963).PubMedGoogle Scholar
  3. Adamson, K., jr., Behrman, R., Dawes, C. S., Dawkins, M. J. R., James, L. S., Ross, B. B.: The treatment of acidosis with alkali and glucose during asphyxia on foetal rhesus monkeys. J. Physiol. (Lond.) 169, 679–689 (1963).Google Scholar
  4. Adamson, K., jr., James, L. S., Koford, O.: Resuscitation by positive pressure ventilation and Tris-hydroxymethylaminomethane of rhesus monkeys asphyxiated at birth. J. Pediat. 65, 807–818 (1964).Google Scholar
  5. Aldinger, E. E., Darby, T. D., Thrower, W. B.: Effects of THAM on acid-base derangements and ventricular contractile force changes elicited by periods of reduced circulatory blood volume. Fed. Proc. 19, 102 (1960).Google Scholar
  6. Andersen, M. N., Border, J. R., Mouritzen, C. V.: Acidosis, Catecholamines and cardiovascular dynamics: when does acidosis require correction? Ann. Surg. 166, 344–356 (1967).PubMedGoogle Scholar
  7. Battaglia, F. C, Behrman, R., Hellegers, A. E.: Intracellular hydrogen ion concentration changes during acute respiratory acidosis and alkalosis. J. Pediat. 66, 737–746 (1965).PubMedGoogle Scholar
  8. Bekemeier, H., Rumler, W.: Zur akuten Toxizität und nephrokalzikotropen Wirkung von Trishydroxymethyl-aminomethan und einigen seiner Salze. Acta biol. med. germ. 17, 217–220 (1966).PubMedGoogle Scholar
  9. Benesch, R. E., Benesch, R.: The stability of the silver complex of tris(hydroxymethyl)-aminomethan. J. Amer. chem. Soc. 77, 2749–2750 (1955).Google Scholar
  10. Bennett, T. E., Tarail, R.: The hypoglycemic activity of 2-amino-2-hydroxy- methyl-1,3-propanediol. Ann. N. Y. Acad. Sci. 92, 651–661 (1961).Google Scholar
  11. Bleich, H. L., Schwartz, W. B.: Tris buffer (THAM): An appraisal of physiologic effects and clinical usefulness. New. Engl. J. Med. 274, 782–787 (1966).PubMedGoogle Scholar
  12. Bretscher, J.: Die Problematik von pH-Messungen aus Mikroblutproben. Pädiat. Pädol. 3, 146–156 (1967).Google Scholar
  13. Brinkman, G. L.: The use of THAM to prevent hyperventilation and acidosis while breathing carbon dioxide. Amer J. med. Sci. 239, 728–731 (1960).Google Scholar
  14. Brinkman, G. L., Brunswick, W. L., Whitehouse, F. W.: The use of 2-amino-2-hydroxy-methyl-1,3-propanediol in the correction of metabolic and respiratory acidosis. Ann. N.Y. Acad. Sci. 92, 735–742 (1961).Google Scholar
  15. Brinkman, G. L., Remp, D. C., Coates, E. O., Priest, E. M.: The Treatment of Respiratory Acidosis with THAM. Amer. J. Med. Sci. 239, 341–346 (1960).PubMedGoogle Scholar
  16. Brown, E. S., Bennett, T. E., Bunnell, I. L., Blam, J. O., Evers, J. L., Greene, D. G., Janney, C. D., Lowe, H. J., Nahas, G. G., Tarail, R.: Effects of THAM during CO2 breathing in man: ventilation and CO2 exchange. Physiologist 2, 18 (1959).Google Scholar
  17. Buckley III, C. E., Sieker, H.: Effects of an organic amine buffer (THAM) on congestive heart failure. Circulation 24, 897 (1961).Google Scholar
  18. Chapman, S. R., Smith, L. M., Simmons, D. H.: Determination of 2-amino-2-hydroxymethyl-l,3-propanediol (Tris; THAM) in urine by titration. J. Lab. clin. Med. 66, 698–704 (1965).PubMedGoogle Scholar
  19. Christensen, H. N., Clifford, J.: Test for metabolic attack on Tris-(hydroxymethyl)-aminomethane and L-Hydroxymethylserine in the rat. Proc. Soc. exp. Biol. (N.Y.) 111, 140–143 (1962).Google Scholar
  20. Clark, jr., I. C.: The use of amine buffers in cardiovascular surgery. Ann. N.Y. Acad. Sci. 92, 687–703 (1961).Google Scholar
  21. Conant, J. S., Hughes, R. E.: The usefulness of THAM in metabolic acidosis. Ann. N.Y. Acad. Sci. 92, 751–754 (1961).PubMedGoogle Scholar
  22. Cramer, L. M., Hinshaw, J. R.: Further experience in the use of tris buffer in the treatment of severely burned patients. Plast, reconstr. Surg. 35, 76–84 (1965).Google Scholar
  23. Darby, T. D.: Effects of 2-amino-2-hydroxymethyl-l,3-propanediol during shock and catecholamine administration. Ann. N.Y. Acad. Sci. 92, 674–686 (1961).PubMedGoogle Scholar
  24. Darby, T. D., Aldinger, E. E., Thrower, W. B., Westbrock, S. H.: Effects of tris(hydroxymethyl)aminomethane (THAM) on ventricular contractile force changes accompanying lactic acid infusion or elevation of ventilation CO2. Fed. Proc. 19, 103 (1960).Google Scholar
  25. Darby, T. D., Anderson, S. J.: Tolerance and toxicitiy of THAM. Ann. Anesth. Franç. 7, 585–592 (1966).Google Scholar
  26. Dawes, G. S., Hibbard, E., Windle, W. F.: The effect of alkali and glucose infusion on permanent brain damage in rhesus monkeys asphyxiated at birth. J. Pediat. 65, 801–806 (1964).PubMedGoogle Scholar
  27. Degering, E. F.: An Outline of Organic Nitrogen Compounds, pp. 61–106. University Lithoprinters, Ypsilanti, Michigan, 1945.Google Scholar
  28. Dos, S. J., Nahas, G. G., Papper, E. M.: Experimental correction of hypercapnic intracranial hypertension. Anesthesiology 23, 46–50 (1962).PubMedGoogle Scholar
  29. Dos, S. J., Randolph, W. A., Jacobson, J. Y., Nahas, G. G., Papper, E. M.: Effects of 2-amino-2-hydroxy-methyl-l,3-propanediol on intracranial hypertension. Ann. N.Y. Acad. Sci. 92, 640–650 (1961).PubMedGoogle Scholar
  30. Elkinton, J. R., Squires, R. D., Singer, R. B.: Intracellular cation exchanges in acidosis due to renal insufficiency. Effects of alkali therapy. J. clin. Invest. 30, 381–387 (1951).PubMedGoogle Scholar
  31. Epstein, R. M., Nahas, G. G., Mark, L. C.: Circulatory changes following rapid correction of severe hypercapnic acidosis by 2-amino-2-hydroxy- methyl-1,3-propanediol. Ann. N.Y. Acad. Sci. 92, 500–507 (1961).PubMedGoogle Scholar
  32. Ewerbeck, H., Hager, J., Welte, W.: Tris-Pufferbehandlung schwerer Verbrennungen bei Kindern zur Vermeidung von Hirndauerschäden. Dtsch. med. Wschr. 91, 1333–1338 (1966).Google Scholar
  33. Ewerbeck, H., Krüger, M.: Die quantitative Acidosebekämpfung—ein Fortschritt in der Behandlung der Säuglingsintoxikationen. Dtsch. med. Wschr. 90, 2141–2145 (1965).PubMedGoogle Scholar
  34. Frenzel, J., Rogner, G.: Klin. Beiträge zur Behandlung der respiratorischen Insuffizienz reifer und unreifer Neugeborener. Mschr. Kinderheilk. 115, 471–476 (1967).PubMedGoogle Scholar
  35. Frenzel, J., Maak, B.: Veränderungen des Lactat/Pyruvat-Quotienten bei hypoxischen Neugeborenen unter der Puffertherapie. Mschr. Kinderheilk. 116, 547–552 (1968).PubMedGoogle Scholar
  36. Friehs, G.: Erfahrungen mit TRIS (THAM) bei der Behandlung der metabolischen Acidóse. Wien. med. Wschr. 117, 1008–1011 (1967).Google Scholar
  37. Gandy, G., Partridge, J. W., Gairdner, D.: Control of acidosis during exchange transfusion with citrated blood. Arch. Dis. Child. 43, 147–150 (1968).PubMedGoogle Scholar
  38. Gemmill, W. D., Sechrist, G. L., Oliver, T. K., jr., Weeler, W. E.: The use of tris buffer to alkalinize the urine of young children with severe salicylism. J. Pediat. 63, 732 (1963).Google Scholar
  39. Gidion, R., Fleischhauer, G., Sinios, A.: Die Therapie der Acidose bei unreifen und reifen Neugeborenen. Ein Erfahrungsbericht über 123 Behandlungen. Z. Kinderheilk. 97, 195–208 (1966).Google Scholar
  40. Gjessing, J.: Peritoneal dialysis using tris (hydroxymethyl) aminomethane (THAM) in the treatment of barbiturate poisoning. Opuscula Med. 10, 153–156 (1965).Google Scholar
  41. Gleichmann, U., V. Stuckrad, H., Zindler, M.: Intracellulärer Säurebasen- und Elektrolythaushalt. Experimentelle und klinische Untersuchungen an Erythrozyten. Z. ges. exp. Med. 139, 255–266 (1965).PubMedGoogle Scholar
  42. Glöckner, J.: Die Behandlung schwerer Acidosen beim Kind mit Tromethamin. Dissertation Köln 1971.Google Scholar
  43. Goldenberg, V. E., Wiegenstein, L., Hopkins, G. B.: Hepatic injury associated with tromethamine. J. Amer. med. Ass. 205, 81–84 (1968).Google Scholar
  44. Gootlieb, S. F., Jagodzinski, R. V.: Role of THAM in protecting mice against convulsive episodes caused by exposure to oxygen under high pressure. Proc. Soc. exp. Biol. (N.Y.) 112, 427–430 (1963).Google Scholar
  45. Gupta, J. M.: The Effect of THAM on the Oxygen Tension of Arterial Blood in Neonatal Respiratory-Distress Syndrome. Lancet I., 734–735 (1965).Google Scholar
  46. Gupta, J. M., Dahlenburg, G. W., Davis, J. A.: Changes in blood gas tensions following administration of amine buffer THAM to infants with respiratory distress syndrome. Arch. Dis. Child. (L.) 42, 416–427 (1967).Google Scholar
  47. Hall, I. H.: Effectiveness of THAM in Preventing Cellular Damage Resulting From Oxygen Lack. Proc. Soc. exp. Biol. (N.Y.) 122, 1240–1244 (1966).Google Scholar
  48. Hartmann, A. F., Senn, M. J. E.: Studies in the metabolism of sodium-Lactate II. Response of human subjects with acidosis to the intravenous injection of sodium-Lactate. J. clin. Invest. 11, 337–344 (1932).PubMedGoogle Scholar
  49. Hass, H. B., Riley, E. F.: The Nitroparaffins. Chem. Rev. 32, 373–430 (1943).Google Scholar
  50. Heese, D.-D.: Versuche zur Acidosebekämpfung bei atemgestörten Neu- und Frühgeborenen mit Tris(hydroxymethyl)aminomethan. Inaug. Dissertat. Köln 1966.Google Scholar
  51. Heidenreich, O., Laaff, H., Fülgraff, G.: Über die renale Ausscheidung von Trispuffer (THAM) und das Anionenmuster im Harn. Med. Pharmacol, exp. 17, 207–213 (1967).Google Scholar
  52. Heine, W., Kellner, R.: Zur Anwendung der Peritoneal-Dialyse bei schwersten toxischen Ernährungsstörungen des Säuglingsalters. Kinderärztl. Prax. 36, 433–440 (1968).Google Scholar
  53. Heiming, E., Rehder, H.: Organschäden nach Trispuffer-Injektion in die Nabelgefäße. Dtsch. med. Wschr. 98, 305 (1973).PubMedGoogle Scholar
  54. Henry, L.: Formation synthetique d/alcools nitres. C. R. Acad. Sci. Paris 126, 1265–1268 (1895).Google Scholar
  55. Henschler, D., Meyer, W.: Hemmung toxischer Lungenödeme und des Verbrennungsödems durch Tris (hydroxymethyl-aminomethan). Klin. Wschr. 40, 264–266 (1962).PubMedGoogle Scholar
  56. Holmdahl, M. H.: The use of tris (hydroxymethyl) aminomethane during short periods of apneic oxygenation in man. Ann. N.Y. Acad. Sci. 92, 794–801 (1961).PubMedGoogle Scholar
  57. Holmdahl, M. H., Hedstrand, U., Parrow, A., Korkeila, J., Telivuo, L., Matell, G.: Association Respiration Artificielle-Tham au Cours du Traitement de l’Etat de mal Asthmatique. Presse Med. 75, 957–960 (1967).PubMedGoogle Scholar
  58. Holmdahl, M. H., Nahas, G. G.: Volume of distribution of C14 labeled tris (hydroxymethyl) aminomethane. Amer. J. Physiol. 202, 1011 (1962).PubMedGoogle Scholar
  59. Holmdahl, M. H., Nahas, G. G., Hassam, D., Verosky, M.: Acid-base changes in the cerebrospinal fluid following rapid changes in the bicarbonate/carbonic acid ratio in the blood. Ann. N.Y. Acad. Sci. 92, 520–527 (1961).PubMedGoogle Scholar
  60. Holmdahl, M. H., Telivuo, L., Korkeila, J.: The use of THAM and artificial ventilation in severe status Asthmaticus. Ann. Anesth. Franç. 8, 117–120 (1966).Google Scholar
  61. Honig, C: Alkalisierende Infusievloeistoffen. Pharm. Weekbl. 100, 667–672 (1965).PubMedGoogle Scholar
  62. Hutchison, J. H., Kerr, M. M., Douglas, T., Inall, J., Crosbie, J.: A therapeutic approach in 100 cases of respiratory distress syndrome of the newborn infant. Pediatrics 33, 956–964 (1964).PubMedGoogle Scholar
  63. Hutchison, J. H., Mcphail, M. F. M., Douglas, T. A., Smith, G., Norman, J. W., Bates, E. H.: Studies in the treatment of the pulmonary syndrome of the newborn. Lancet II, 465–469 (1962).Google Scholar
  64. Irvine, R. O. H., Dow, J. W.: Sodium Bicarbonate, Sodium Lactate and Tris Buffer in the Treatment of Acute Metabolic Acidosis. Clin. Res. 13, 237 (1965).Google Scholar
  65. Israel, S., Davies, H.: The Effect of THAM on reexcretion of Salicylate. Amer. J. Dis. Childh. 102, 744–747 (1961).Google Scholar
  66. Jarre, W., Ketterle, W., Reinwein, H.: Zur Behandlung des Respiratory-Distress-Syndrome bei Frühgeborenen mit Tris-(hydroxymethyl)-aminomethan (THAM) und Netzmittel. Helv. paediat. Acta 20, 27–39 (1965).PubMedGoogle Scholar
  67. Jonxis, J. H. P.: Tris-PufFer bei der Behandlung des „Respiratory Distress Syndrome”. Pädiat. Pädol. 3, 231–236 (1967).Google Scholar
  68. Jørgensen, K., Astrup, P.: The effect of 2-amino-2-hydroxymethyl-l,3-propanediol on blood-buffering capacity. Ann. N.Y. Acad. Sci. 92, 491–499 (1961).PubMedGoogle Scholar
  69. Kaplan, S. A.: Tris (hydroxymethyl) aminomethane (THAM) a new buffer for therapeutic use. Amer. J. Dis. Childh. 103, 1–3 (1962).Google Scholar
  70. Kaplan, S. A., Fox, R. P., Clark, L. C.: Amine buffers in the management of acidosis. Amer. J. Diss. Childh. 103, 4–9 (1962).Google Scholar
  71. Karetzky, M. S., Mithoefer, J. C.: The renal excretion of sodium and bicarbonate following NaHCO3 infusion in patients with respiratory acidosis. Amer. J. med. Sci. 254, 851–854 (1967).PubMedGoogle Scholar
  72. Kellner, R.: Pharmakologie und klinische Verwendung des Trishydroxy-methylaminomethan. Pädiat. Pädol. 3, 95–112 (1967).Google Scholar
  73. Kellner, R., Heine,W., Becker, H.: Vergleichende klinische und pathologisch-anatomische Untersuchungen über den Effekt der Azidosebehandlung beim „respiratory distress Syndrome” der Frühgeborenen. Pädiat. Grenzgeb. 5, 255–266 (1966).Google Scholar
  74. Keuth, U.: Natriumbikarbonat-Glucose-Infusion beim Membransyndrom der Früh- und Neugeborenen. Dtsch. med. Wschr. 92, 248 - 255 (1967).Google Scholar
  75. Kilman, J. S., Vasko, J. S.: The Effect of THAM on the electrolytes and urinary output of patients undergoing extracorporeal circulation. Clin. Res. 15, 210 (1967).Google Scholar
  76. Kirchheim, H.: Die Wirkung von Tris (hydroxymethyl) Aminomethan(THAM) auf die Nierendurchblutung im haemorrhagischen Schock. Pflügers Arch. ges. Physiol. 286, 323–335 (1965).Google Scholar
  77. Knöchel, J. P., Barry, K.-G., Clayton, L. E., Smith, W. L.: THAM-Dialysis: An experimental method to study diffusion of certain weak acids in vivo II. Secobarbital. J. Lab. clin. Med. 65, 361–369 (1965).Google Scholar
  78. Korkeila, J., Vapaavuori, M.: THAM and Engström respirator in the treatment of peptic aspiration pneumonitis (a case report). Ann. Chir. Gynaec. Fenn. 52, 124–131 (1963).PubMedGoogle Scholar
  79. Krause, W.: Tris-Pufferbehandlung (THAM) bei „depressed infants”. Z. Beburtsh. Gynäk. 169, 158–186 (1968).Google Scholar
  80. Kress, G.: Une nouvelle amine tampon: Le THAM Considérations physiopathologiques et thérapeutiques. Presse méd. 71, 2652 (1963).Google Scholar
  81. Krüger, M.: Die Laktatbehandlung der Säuglingsintoxikation. Dissertation Köln 1965.Google Scholar
  82. Kuwabara, S., Aochi, O.: Management of acid-base imbalance during open heart surgery: Comparison of the effects of tris-buffer and bicarbonate. Jap. J. Anesth. 17, 155–159 (1968).Google Scholar
  83. Larcan, A., Herbenval, R.: Le THAM en diabétologie. Ann. Anesth. franç. 7, 887–894 (1966).Google Scholar
  84. Lee, W. H., Darby, T. D., Aldinger, E. E., Thrower, W. B.: Use of THAM in the management of refractory cardiac arrest. Amer. Surg. 28, 87–89 (1962).Google Scholar
  85. Levy, N., Rose, J. D.: The aliphathic nitro-compounds. Quart. Rev. 1, 358–395 (1947).Google Scholar
  86. Linn, S., Roberts, M.: Microassay of Tris (Hydroxymethyl) aminomethane applicable to blood and urine. Ann. N. Y. Acad. Sci. 92, 419–425 (1961).PubMedGoogle Scholar
  87. Loeb, H., Ooms, H. A., Duvivier, A.: Etude de l’action hypoglycemiante du THAM chez l’enfant. Ann. Anesth. franç. 7, 879–884 (1966).Google Scholar
  88. Luchsinger, P.C., Berman, L. B.: Carbon dioxide buffering in pulmonary disease. Clin. Res. 8, 255 (1960).Google Scholar
  89. Malm, J. R., Bowman, F. O. jr., Sullivan, S. F., Nahas, G. G.: The use of tham buffered acid-dextrose citrate blood for extracorporeal circulation. J. cardiovasc. Surg. (Torino) 6, 134–137 (1965).Google Scholar
  90. Malm, J. R., Manger, W. M., Sullivan, S. F., Papper, E. M., Nahas, G. G.: The Effect of Acidosis on Sympathoadrenal Stimulation. Particular Reference to Cardio-pulmonary Bypass. J. Amer. med. Ass. 197, 121–125 (1966).Google Scholar
  91. Manfredi, F., Sieker, H. O., Spoto, A. P., Saltzman, H. A.: Severe carbon dioxide intoxication. Treatment with organic buffer (Trishydroxymethyl-aminomethane). J. Amer. med. Ass. 173, 999–1003 (1960).Google Scholar
  92. Marenk, K.: Die Phosphor- und Ammoniak-Ausscheidung im 24-Stunden-Harn acidotischer Kinder nach Tromethamin (TH AM)-Infusion. Dissertation Köln 1968.Google Scholar
  93. Massaro, D. J., Katz, S., Luchsinger, P. C: The carbon dioxide buffer (trishydroxymethylaminomethane) in the treatment of respiratory acidosis. Amer. Rev. resp. Dis. 86, 353–359 (1962).PubMedGoogle Scholar
  94. Moore, F. D., Bernhard, W. F.: Efficacy of 2-amino-2-hydroxymethyl-l,3-pro- panediol (Trisbuffer) in management of metabolic Lactacidosis accompanying prolonged hypothermic perfusion. Surgery 52, 905–912 (1962).Google Scholar
  95. Nahas, G. G.: Use of an organic carbon dioxide buffer in vivo. Science 129, 782–783 (1959).PubMedGoogle Scholar
  96. Nahas, G. G.: The clinical pharmacology of THAM (tris/hydroxymethyl/aminomethane). Clin. Pharmacol. Ther. (St. Louis) 4, 784–803 (1963).Google Scholar
  97. Nahas, G. G.: L’utilisation du tris (hydroxyméthyl) aminométhane (THAM) dans le traitement des brulures graves. Presse méd. 72, 1301 (1964).PubMedGoogle Scholar
  98. Nahas, G. G.: The use of buffers in the management of respiratory failure. Ann. N. Y. Acad. Sci. 121, 871–882 (1965).PubMedGoogle Scholar
  99. Nahas, G. G.: Tris-Buffer vs sodium bicarbonate. New. Engl. J. Med. 275, 1203–1204 (1966).Google Scholar
  100. Nahas, G. G., Dos, S. J., Ligou, J. C.: The hypoglycemic activity of THAM. Clin. Res. 8, 27 (1960).Google Scholar
  101. Nahas, G. G., Giroux, J. J., Cjessing, J., Verosky, M., Mark, L. G: The use of THAM in peritoneal dialysis. Trans. Amer. Soc. artif. intern. Org. 10, 345–347 (1964).Google Scholar
  102. Nahas, G. G., Jordan, E. C., Ligou, J. C.: Effects of a “CO2-buffer” on hypercapnia of apneic oxygenation. Amer. J. Physiol. 197, 1308–1316 (1959).PubMedGoogle Scholar
  103. Nahas, G. G., Lumpkin, M. L.: The effects of THAM on the ventilation of the resting dog. Physiologist 2, 87–88 (1959).Google Scholar
  104. Nahas, G. G., Malm, J.-R., Manger, W.-M., Verosky, M., Sullivan, F.: Le contröle de Pacidose et l’utilisation du sang citrate neutralise en Chirurgie cardiaque. Presse méd. (Paris) 72, 657–660 (1964).Google Scholar
  105. Nahas, G. G., Manger, W. M., Hassam, D., Papper, E. M.: Effect of pH control and increased O2 delivery on the course of hemorrhagic shock. Fed. Proc. 21, 117 (1962).Google Scholar
  106. Nahas, G. G., Reveillaud, R. J., Strauss, J., Schwartz, I., Verosky, M.: Renal effect of tris (hydroxymethyl)-aminomethane during CO2 load. Amer. J. Physiol. 204, 113–118 (1963).PubMedGoogle Scholar
  107. Nahas, G. G., Roebuck, M. J., Mark, L. C.: Effect of hypertonic NaCl on cardiac arrhythmias. Amer. J. Physiol. 203, 1125–1129 (1962).PubMedGoogle Scholar
  108. Nahas, G. G., Verosky, M.: The storage of CO2 during apneic oxygenation. Ann. N.Y. Acad. Sci. 133, 134–141 (1966).PubMedGoogle Scholar
  109. Nahas, G. G., Schwartz, I.: Urinary excretion of THAM citrate orally administered. Proc. Soc. exp. Biol. (N.Y.) 116, 378–382 (1964).Google Scholar
  110. Neimann, N., Vert, P., Marchal, C.: Pediatric applications of THAM. Ann. Anesth. frans. 7, 861–876 (1966).Google Scholar
  111. Nessler, G.: Behandlung der diabetischen Acidose mit Trispuffer. Arch. Kinderheilk. 178, 240–257 (1969).PubMedGoogle Scholar
  112. Neuhausen, H.-J.: THAM-(tris-hydroxymethyl-aminomethan)ausscheidung bei acidotischen Kindern nach intravenöser Dauertropfinfusion. Dissertation Köln 1968.Google Scholar
  113. Nishimura, K., Goshi, C., Kasahara, H.: Results of treatment of idiopathic respiratory distress of newborn by continuous intravenous drip of trisbuffer, J. Jap. Soc. Pediat. 72, 256–264 (1968).Google Scholar
  114. Oliver, T. K.: The use of THAM-buffered ACD blood in high risk infants who require exchange transfusion. J. Pediat. 67, 951 (1965).Google Scholar
  115. Oppe, Th. E., Priestley, B. L., Redstone, D.: Metabolic changes in the infant with respiratory failure. Ped. clin. N. Amer. 12, 723–742 (1965).Google Scholar
  116. Pahnke, V.: Einfluß von Thromethamin auf Serumelektrolytkonzentrationen und Harnstoff im Serum. Dissertation Köln 1971.Google Scholar
  117. Peirce II., E.: The correction of acidosis with tris(hydroxymethyl)aminomethane. Arch. Surg. 80, 693 (1960).PubMedGoogle Scholar
  118. Pierson, W. E., Barrett, C. T., Oliver, T. K.: The effect of buffered and non-buffered ACD blood on electrolyte and acid-base homestasis during exchange transfusion. Pediatrics 41, 802–814 (1968).PubMedGoogle Scholar
  119. Piloty, O., Ruff, O.: Uber die Reduktion des tertiären Nitroisobutylglycerins und das Oxim des Dioxyacetons. Ber. dtsch. ehem. Ges. 30, 1656–1665 (1897).Google Scholar
  120. Posner, J. B., Plum, F.: Spinal-fluid pH and neurologic symptoms in systemic acidosis. New Engl. J. Med. 277, 605–613 (1967).Google Scholar
  121. Quellhorst, E., Heimburg, P., Willms, B., Reichart, U., Scheler, F.: Untersuchungen über die Anwendung von Trispuffer bei schwerer Niereninsuffizienz. Klin. Wschr. 44, 1243–1247 (1966).PubMedGoogle Scholar
  122. Retzlaff, G., Hutschenreuter, K.: Klinische Nebenwirkungen THAM-haltiger Plasmaexpander. Anaesthesiologie u. Wiederbelebung 17, 68–69 (1966).Google Scholar
  123. Richards, R. K.: Records, of the Division of Experimental Therapy, Abbott Laboratories.Google Scholar
  124. Richards, W., Siegel, S. C, Strauss, J., Leigh, M. D.: Status asthmaticus in children. J. Amer. med. Ass. 201, 75–81 (1967).Google Scholar
  125. Roberts, M., Linn, S.: Acute and subchronic toxicity of 2-amino-2-hydroxy- methyl-l,3-propanediol. Ann. N.Y. Acad. Sci. 92, 724–734 (1961).PubMedGoogle Scholar
  126. Roberts, P., Thornefeldt, R., Langley, I. I., Mark, C: Immediate treatment of respiratory distress in the newborn. Amer. J. Obstet. Gynec. 101, 293–297 (1968).PubMedGoogle Scholar
  127. Robin, E. D., Wilson, R. J., Bromberg, P.: Intracellular acid-base relations and intracellular buffers. Ann. N.Y. Acad. Sci. 92, 539–546 (1961).PubMedGoogle Scholar
  128. Rosen, H.: Quantitative measurement of the amine buffer: 2-amino-2-hydroxy- methyl-1,3-propanediol. Ann. N.Y. Acad. Sci. 92, 414–418 (1961).PubMedGoogle Scholar
  129. Rumler, W., Sitka, U.: Über die Acidóse bei der Säuglingstoxikose und ihre Behandlung mit THAM. Z. Kinderheilk. 103, 52–60 (1968).PubMedGoogle Scholar
  130. Russell, G., Cotton, E. K.: Effects of sodium bicarbonate by rapid injection and of oxygen in high concentration in respiratory distress syndrome of the newborn. Pediatrics 43, 1065–1073 (1968).Google Scholar
  131. Saling, E., Bretscher, J.: Pufferinjektion in die Vena umbilicalis des noch nicht abgenabelten Neugeborenen. Geburtsh. u. Frauenheilk. 28, 63–70 (1968).Google Scholar
  132. Samiy, A. H., Ramsay, A. G., Rees, S. B., Merrill, J. P.: The use of 2-amino-2-hydroxymethyl-l,3-propanediol in the management of renal acidosis. Ann. N.Y. Acad. Sci. 92, 802–812 (1961).PubMedGoogle Scholar
  133. Samiy, A. H., Rees, S. B., Younger, M. D., Freedlander, A. E., Root, H. J.: The use of tris buffer in the management of diabetic aicosis. IV Cong. Fed. Internat. Diabet. (Geneva), Prod. III, 578–580 (1961).Google Scholar
  134. Savignoni, P. G., Bucci, G., Ceccamea, A., Menduni, M., Salamandre, A., Orzalesi, M. M.: Intravenous Infusion of Glucose and sodium bicarbonate in hyaline membrane disease. Acta paediat. scand. 58, 1–9 (1969).PubMedGoogle Scholar
  135. Sessler, A. D., Taswell, H. F., Moffitt, E. A., Kirklin, J. W.: Heparinized versus Acid-Citrate-Dextrose-Blood for cardiopulmonary bypass. Mayo Clin. Proc. 40, 859–876 (1965).PubMedGoogle Scholar
  136. Siegel, L.: The Effect of Inorganic Ions on the Structure and Function of Mitochondrial Malic Dehydrogenase from Bovine Heart Muscle. Biochemistry 6, 2261–2267 (1967).PubMedGoogle Scholar
  137. Sieker, H. O., Merwarth, C. R., Saltzman, H. A., Manfredi, F.: The use of 2-amino-2-hydroxymethyl-l,3-propanediol in severe carbon dioxide intoxication. Ann. N.Y. Acad. Sci. 92, 783–793 (1961).Google Scholar
  138. Sinclair, J. C., Engel, K., Silverman, W. A.: Early correction of hypoxemia and acidemia in infants of low birth weight: A controlled trial of Oxygen breathing, rapid alkali infusion, and assisted ventilation. Pediatrics 42, 565–589 (1968).PubMedGoogle Scholar
  139. Singer, R. B., Clark, J. K., Barker, E. S., Crosley, A. P., jr., Elkington, J. R.: Acute effects in man of rapid intravenous infusion of hypertonic sodium bicarbonate solution-I. Changes in acid-base balance and distribution of excess buffer base. Medicine 34, 51–95 (1955).PubMedGoogle Scholar
  140. Swan, R. C., Axelrod, D. R., Seip, M., Pitts, R. F.: Distribution of sodium bicarbonate infused into nephrectomized dogs. J. clin. Invest. 34, 1795–1801 (1955).PubMedGoogle Scholar
  141. Swanson, A. G.: Potential harmful effects of treating pulmonary encephalopathy with a carbon dioxide buffering agent. Amer. J. med. Sci. 240, 433–437 (1966).Google Scholar
  142. Schippan, R.: Verhalten des Säure-Basen-Haushaltes des Blutes nach schneller THAM-Infusion. Pädiat. Grenzgeb. 6, 105–115 (1967).Google Scholar
  143. Schloss, O. M., Stetson, R. F.: The occurrence of acidosis with severe diarrhea. Amer. J. Dis. Childh. 13, 218–230 (1917).Google Scholar
  144. Schobess, F. C.: Uber das Verhalten von Standardbikarbonat und aktuellem pH während der Behandlung der Säuglingsintoxikation. Inaugur. Dissert. Med. Fak. Köln 1962.Google Scholar
  145. Schöber, J. G., Tympner, K.-D., Bühlmeyer, K.: Der Säurebasenhaushalt bei angeborenen, cyanotischen Herzvitien und seine Bedeutung für die prä- und Postoperative Behandlung. Klin. Wschr. 45, 282–288 (1967).PubMedGoogle Scholar
  146. Schwartz, W. B., Waters, W. C.: Lactate versus bicarbonate. A reconsideration of the therapy of metabolic acidosis. Amer. J. Med. 32, 831–834 (1962).PubMedGoogle Scholar
  147. Schweizer, O., Howland, W. S.: Significance of lactate and pyruvate according to volume of blood transfusion in man: effect of exogenous bicarbonate buffer on lacticacidemia. Ann. Surg. 162, 1017–1027 (1965).PubMedGoogle Scholar
  148. Stahlman, M.: Treatment of cardiovascular disorders of the newborn. Pediat. Clin. N. Amer. 11, 363–400 (1964).PubMedGoogle Scholar
  149. Stoneman, M. E. R., Owens, R. M.: Effects of intragastric sodium bicarbonate in infants with respiratory distress. Arch. Dis. Childh. 43, 155–160 (1968).PubMedGoogle Scholar
  150. Strauss, J.: Tris(hydroxymethyl)aminomethane (THAM): A Pediatric evaluation. Pediatrics 41, 667–689 (1968).PubMedGoogle Scholar
  151. Strauss, J., Bernath, K., Kaplan, S. A.: Determination of Tris-(Hydroxy methyl)-Amino Methane (THAM). Proc. Soc. exper. Biol. (N.Y.) 113, 58–61 (1963).Google Scholar
  152. Strauss, J., Fine, R. N., Medina, D. A., Donnell, G. N.: The use of THAM in the treatment of status asthmaticus. Pediatrics 38, 655–657 (1966).PubMedGoogle Scholar
  153. Strauss, J., Nahas, G. G., Clark, H.: Conservative treatment of acute salicylate intoxication. Ann. Anesth. franç. 7, 909–912 (1966).Google Scholar
  154. Tarail, R., Bennett, T. E., Brown, E. S., Bunnell, I. L., Elam, J. O., Evers, J. J., Greene, D. G., Janney, C. D., Lowe, H. J., Nahas, G. G.: Effects of THAM during COA breathing in man: metabolic and toxic effects. Physiologist 2, 114 (1959).Google Scholar
  155. Thompson, R. G., Moulder, P. V., Harrison, R. W., Daicoff, G. R.: Tromethamine (Talatrol) for acidosis therapy in surgery. Surg. Clin. N. Amer. 43, 179–184 (1963).PubMedGoogle Scholar
  156. Thompson, S. W., Allen, M. R., McDowell, M. E.: Toxicity Studies with Tris(hydroxymethyl)aminomethane. U.S. Army Med. Res. and Nutritional Laboratory Rep. 285 (1965).Google Scholar
  157. Troelstra, J. A., Jonxis, J. H. P., Visser, H. K. A., Van der Vlugt, J. J.: Behandeling van het hyaliene-membranensyndrom met glucose, tris-hydroxy-methyl-aminomethaan (THAM) en bicarbonaat. Ned. T. Geneesk. 109, 454–456 (1965).Google Scholar
  158. Tzonos, T.: Untersuchungen über das Hirnödem und seine Beeinflußbarkeit im Tierversuch. In: Kienle, G. (Hrsg.) Hydrodynamik, Elektrolyt- und Säure-Basen-Haushalt im Liquor und Nervensystem, S. 248–258. Stuttgart: Georg Thieme 1967.Google Scholar
  159. Usher, R.: The respiratory distress syndrome of prematurity. Ped. Clin. N. Amer. 8, 525–538 (1961).Google Scholar
  160. Usher, R.: Reduction of mortality from respiratory distress syndrome of prematurity with early administration of intravenous glucose and sodium bicarbonate. Pediatrics 32, 966–975 (1963).PubMedGoogle Scholar
  161. Van Slyke, D. D.: On the measurement of buffer values and on the relationship of buffer value to the dissociation constant of the buffer and the concentration and reaction of the buffer solution. J. biol. Chem. 52, 525–570 (1922).Google Scholar
  162. Vercruysse, G., Weissenbacher, G., Zweymüller, F.: Tris(hydroxymethyl)-aminomethan (THAM) zur Addosebehandlung bei Kindern. Wien. klin. Wschr. 78, 765–774 (1966).Google Scholar
  163. Vert, P., Marchal, C., Neimann, N., Pieron: Traitement symptomatique des acidoses rénales par administration orale de citrate de THAM. Arch, franç. Pédiat. 25, 91–102 (1968).Google Scholar
  164. Voute, P. A., jr.: Behandeling van Acidose met THAM-buffer bij zuigelingen. Ned. T. Geneesk. 110, 1237 (1966).Google Scholar
  165. Wadell, W. J., Butler, T. C.: Calculation of intracellular pH from the distribution of 5,5-dimethyl-2,4-oxazolidine-dione (DMO) Application to skeletal muscle of the dog. J. clin. Invest. 38, 720–729 (1969).Google Scholar
  166. Wasserscheid, B.: Einfluß von THAM auf Haemokonzentration und Blutzucker bei Kindern. Inaug. Dissert. Med. Fak. Köln, in Vorbereitung.Google Scholar
  167. Wenner, J., Braun, C.: Der Einfluß der Alkalitherapie auf Atmung und Säure-bilanz des Neugeborenen mit idiopathischem Atemnotsyndrom. Pädiat. Pädol. 3, 237–244 (1967).Google Scholar
  168. Yllpö, A.: Neugeborenen-, Hunger- und Intoxikationsacidosis in ihren Be-ziehungen zueinander. 2. Kinderheilk. 14, 268–327 (1916).Google Scholar
  169. Young, D., Robinson, G.: Successful valve replacement in an infant with congenital mitral stenosis. New Engl. J. Med. 270, 660–664 (1964).PubMedGoogle Scholar
  170. Zimmermann, W.: Der TrispufFer in klinischer Anwendung. Dtsch. med. Wschr. 88, 1305–1318 (1963).PubMedGoogle Scholar
  171. Zimmermann, W.: Veränderungen des Säure-Basen-Haushaltes beim traumatischen Schock. In: Lang, K., Frey, R., Halmägyi, M. (Hrsg.) Infusionstherapie, S. 46–56. Springer 1966b.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1974

Authors and Affiliations

  • H. Helwig
    • 1
  1. 1.Kinderkrankenhaus St. HedwigFreiburg i. Br.Germany

Personalised recommendations